ProMIS Neurosciences reckons it has the only assets to tackle the cause of Alzheimer's

(7:7)

ProMIS Neurosciences @ Sachs NIF

(21:25)

ProMIS Neurosciences Whiteboard Final

(1:31)

ProMIS Neurosciences

(2:13)

ProMIS Neurosciences (TSX:PMN) MD, President \u0026 CEO Elliot Goldstein

(22:53)

ProMIS™ Neurosciences, Inc. @ 2nd Annual NIF

(19:51)

Challenges in Alzheimer's Drug Development

(1:26)

ProMIS Neurosciences @ Sachs NIF

(21:25)

ProMIS Neurosciences CEO Eugene Williams on Developing Treatments for Alzheimer’s, MSA, ALS and PD

(11:12)

ProMIS Neurosciences

(24:29)

ProMIS Neurosciences rings Nasdaq closing bell on July 13th,

(5:16)

Biotech Solutions to the Neurodegenerative Crisis

(34:52)

ProMIS Neurosciences Inc. (TSX: PMN) | Stock News Now

(18:44)

Improving the next generation of anti-amyloid antibodies: prioritizing selectivity with PMN310

(4:51)

4th Annual ALS ONE Research Symposium - Presentation by Neil Cashman, MD of ProMis Neurosciences.

(23:57)

Development of a new anti-amyloid antibody PMN310 for the treatment of Alzheimer’s disease

(2:38)

CSO Neil Cashman the science of ProMIS 08 2019

(5:56)

USask Research Minute: Dr. Scott Napper

(4:28)